Continually, strategies to overcome resistance in BID-Bax-deficient tumors, such as approaches aimed at restoring the functionality of the BID-Bax-axis in tumors, upregulating BID-Bax protein expression in patient tumor cells, or alternative combination regimens that bypass this dependency can be emphasized. Here, BID is linked to neoplasm.